恶性黑色素瘤,转移性的临床试验
总计15311个结果
-
SCRI Development Innovations, LLCNovartis完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)完全的
-
Cooperative Research Centre for Biomedical Imaging...未知
-
National Cancer Institute (NCI)完全的
-
Reata, a wholly owned subsidiary of Biogen完全的
-
IO BiotechMerck Sharp & Dohme LLC; Syneos Health主动,不招人转移性黑色素瘤 | 不可切除的黑色素瘤匈牙利, 西班牙, 英国, 澳大利亚, 法国, 意大利, 美国, 丹麦, 德国, 以色列, 捷克语, 比利时, 荷兰, 火鸡, 波兰, 南非
-
National Cancer Institute (NCI)主动,不招人III 期皮肤黑色素瘤 AJCC v7 | IV 期皮肤黑色素瘤 AJCC v6 和 v7 | 晚期恶性实体瘤 | 难治性恶性实体瘤 | 复发性黑色素瘤 | IIIC 期皮肤黑色素瘤 AJCC v7 | IIIA 期皮肤黑色素瘤 AJCC v7 | IIIB 期皮肤黑色素瘤 AJCC v7美国
-
University of Southern CaliforniaNational Cancer Institute (NCI)招聘中
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)完全的转移性黑色素瘤 | IV 期皮肤黑色素瘤 AJCC v6 和 v7 | 不可切除的黑色素瘤 | 粘膜黑色素瘤 | IV 期葡萄膜黑色素瘤 AJCC v7美国
-
California Pacific Medical Center Research InstituteM.D. Anderson Cancer Center招聘中
-
California Pacific Medical Center Research InstituteTesaro, Inc.; Vanderbilt-Ingram Cancer Center; Huntsman Cancer Institute招聘中
-
Hoffmann-La Roche完全的转移性黑色素瘤美国, 加拿大, 比利时, 西班牙, 法国, 俄罗斯联邦, 澳大利亚
-
Parker Institute for Cancer ImmunotherapySeres Therapeutics, Inc.完全的
-
University of LouisvilleJames Graham Brown Cancer Center主动,不招人
-
Abramson Cancer Center of the University of Pennsylvania完全的
-
Novartis Pharmaceuticals完全的
-
Hoffmann-La Roche完全的
-
University Hospital, MontpellierSaint-Louis Hospital, Paris, France完全的
-
John KirkwoodNational Cancer Institute (NCI); National Institutes of Health (NIH)终止
-
University of IowaNovartis Pharmaceuticals; Holden Comprehensive Cancer Center终止
-
Beth Israel Deaconess Medical CenterGenzyme, a Sanofi Company完全的
-
University of PittsburghBristol-Myers Squibb撤销
-
Italian Network for Tumor Biotherapy FoundationAstex Pharmaceuticals, Inc.未知
-
California Pacific Medical Center Research InstitutePfizer; University of California, San Francisco完全的